Qualigen Therapeutics Inc... (QLGN)
NASDAQ: QLGN
· Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 06:37 PM EDT
Qualigen Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 30.21K | 1.17M | 388.15K | 118.69K | 543.22K | 401.8K | 2.07M | 1.34M | 4.36M | 7.03M | 6.62M | 9.75M | 13.61M | 17.54M | 12.32M | 15.23M | 21.95M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.43K | 5.59K | 5.69K | 5.62K | 5.72K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2K | 2K | n/a | n/a | n/a | 866.48K | 866.48K | 23.77K | 23.92K | 24.02K | 23.96K | 24.05K | 18.33K | 18.33K | 18.33K | 18.33K | 18.33K |
Receivables | 2.23M | 2.01M | 1.3M | n/a | n/a | n/a | 235.4K | 679.38K | 411.1K | 538.59K | 603.29K | 719.88K | 594.34K | 822.35K | 633.55K | 766.91K | 862.24K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -235.4K | 1.56M | 1.48M | 1.59M | 1.48M | 1.31M | 1.4M | 1.06M | 1.18M | 1.07M | 885.86K |
Other Current Assets | 585.76K | 31.2K | n/a | n/a | 450K | n/a | n/a | 11.64K | 12.16K | n/a | n/a | n/a | n/a | 3.58K | n/a | n/a | n/a |
Total Current Assets | 2.85M | 4.68M | 2.31M | 534.41K | 1M | 1.17M | 3.45M | 4.86M | 7.54M | 10.82M | 10.4M | 13.7M | 16.7M | 20.8M | 15.73M | 19.11M | 24.92M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.88M | 1.96M | 1.77M | 1.79M | 1.87M | 1.82M | 1.85M | 475.79K | 580.16K | 612.24K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.38M | 6.39M | 6.47M | 10.75M | 10.75M | 164.82K | 171.19K | 177.56K | 183.93K | 189.29K |
Total Long-Term Assets | 2K | 2K | n/a | n/a | n/a | 866.48K | 866.48K | 8.29M | 8.38M | 8.26M | 12.56M | 12.64M | 2M | 2.04M | 671.69K | 782.42K | 819.86K |
Total Assets | 2.85M | 4.69M | 2.31M | 534.41K | 1M | 2.03M | 4.32M | 13.15M | 15.91M | 19.08M | 22.96M | 26.35M | 18.71M | 22.84M | 16.4M | 19.89M | 25.74M |
Account Payables | 1.53M | 1.57M | 1.64M | 1.85M | 1.8M | 2.22M | 1.57M | 1.76M | 899.95K | 857.31K | 596.04K | 918.33K | 997.41K | 886.22K | 908.7K | 784.47K | 485.55K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1.31M | 94.47K | 112.9K | 116.16K | 102.64K | 109.83K | 127.3K | 135.06K | 270.76K | 325.99K | 381.37K |
Short-Term Debt | 843.62K | n/a | 1.43M | 1.67M | 1.02M | 1.3M | 832.1K | 2.03M | 1.77M | 1.41M | 1.14M | 1.12M | 155.53K | 134.09K | n/a | 270.64K | 273.28K |
Other Current Liabilities | 334.56K | 269.18K | 908.62K | 573.22K | 1.14M | 332.61K | 3.31M | 3.41M | 4.52M | 5.08M | 2.13M | 2.71M | 1.74M | 2.35M | 3.3M | 5.22M | 7.46M |
Total Current Liabilities | 2.81M | 2.01M | 4.45M | 4.81M | 4.52M | 4.14M | 5.96M | 8.49M | 8.24M | 8.61M | 4.88M | 5.65M | 3.63M | 4.64M | 5.43M | 7.42M | 9.2M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.3M | n/a | n/a | n/a | n/a | n/a | n/a | 4.92K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.35M | 1.47M | 1.71M | 2.16M | 2.23M | 1.57M | 1.64M | 131.49K | 210.2K | 308.41K |
Total Liabilities | 2.81M | 2.01M | 4.45M | 4.81M | 4.52M | 4.14M | 5.96M | 9.84M | 9.71M | 10.32M | 7.04M | 7.88M | 5.19M | 6.27M | 5.56M | 7.63M | 9.51M |
Total Debt | n/a | n/a | 1.43M | 1.67M | 1.02M | 1.3M | 832.1K | 3.2M | 3M | 2.71M | 2.51M | 2.54M | 1.64M | 1.68M | 303.89K | 368.79K | 446.46K |
Common Stock | 66.2K | 65.31K | 65.31K | 47.51K | 44.4K | 43.26K | 42.95K | 42.95K | 42.95K | 42.11K | 42.11K | 38.8K | 35.3K | 35.29K | 29.08K | 28.9K | 28.83K |
Retained Earnings | -125.71M | -123.06M | -122.21M | -120.41M | -118.84M | -116.8M | -114.35M | -110.7M | -107.23M | -103.39M | -97.01M | -93.19M | -89.06M | -84.74M | -78.68M | -75.83M | -70.52M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | 131.89K | 170.44K | 50.72K | 154.06K | 65.54K | -0.00 | n/a | n/a | n/a | n/a |
Shareholders Equity | 33.13K | 2.68M | -2.14M | -4.28M | -3.52M | -2.1M | -1.64M | 2.03M | 4.87M | 7.24M | 12.15M | 14.47M | 13.52M | 16.56M | 10.85M | 12.26M | 16.23M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.43K | 5.59K | 5.69K | 5.62K | 5.72K | n/a | n/a | n/a | n/a | n/a |